Breath volatile organic compounds for chronic kidney disease progression monitoring-Reference-Cited by-同舟云学术

Breath volatile organic compounds for chronic kidney disease progression monitoring

Published:2024 Issue: Volume: Page:
ISSN:0003-2654
Container-title:The Analyst
language:en
Short-container-title:Analyst

Author:

Li Lei¹²,Wang Jue³,Feng Fei¹²^ORCID,Yan Jiayi³,Zhao Bin¹²,Li Xinxin¹²⁴^ORCID,Zhong Yifei³

Affiliation:

1. State Key Laboratory of Transducer Technology, Shanghai Institute of Microsystem and Information Technology, Chinese Academy of Sciences, Shanghai 200050, China

2. Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, China

3. Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China

4. Xin-Huangpu Joint Innovation Institute of Chinese Medicine, Guangzhou 510799, China

Abstract

A breath volatile organic compound (VOC) combination whose components all increase with chronic kidney disease (CKD) progression is superior to any single component for monitoring CKD progression.

Funder

National Key Research and Development Program of China

Science and Technology Commission of Shanghai Municipality

National Science and Technology Major Project

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

Electrochemistry,Spectroscopy,Environmental Chemistry,Biochemistry,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2024/AN/D3AN01057K

Reference25 articles.

1. Epidemiology of chronic kidney disease: an update 2022

2. Strategies to prevent kidney disease and its progression

3. Patient-centred approaches for the management of unpleasant symptoms in kidney disease

4. Exhaled breath biomarker sensing

5. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease